
Methods: Cross-sectional study conducted between January and May of 2016. Seven 200- to 800-bed hospitals were included. The staff of the hospital-acquired infections committee responsible for the AMSP was interviewed and the basis of the aspects included in the Core Elements of Hospital Antibiotic Stewardship: leadership commitment, accountability, drug expertise, action, tracking, reporting, and education) was verified. The frequency of the results was described.
Results: forty-three per cent of hospitals had a formal, written statement of support and 14% received financial support. One hospital had a single leader in charge of AMSP and two hospitals had pharmacist leaders responsible for improving antibiotic use. Other members of the AMSP staff included clinicians, epidemiologists, and microbiologists (43%), information technologists (29%), and quality improvement personnel and nurse practitioners (14%). None of the hospitals had a clearly defined AMSP policy; 57% considered local epidemiology to make recommendations for antibiotic use (ATB). Twenty-nine per cent pre-approved the use of ATB, while 14% conducted prescription audits; only one hospital performed adjustments in cases of organ dysfunction; 100% met the indication of performing cultures in invasive infections and 43% used strategies to ensure ATB treatment in urinary tract infections. Neither process measures nor track of C. difficileinfection were registered; 43% had an ATB susceptibility report, and in 57%, ATB use was monitored through defined daily dose. Twenty-nine per cent directly informed the report of ATB use to prescribers, and 43% included anti-microbial susceptibility consolidated reports and stated that AMSP educational strategies for hospital personnel were being implemented.
Conclusion: Demonstrating the lack of concordance between the observed AMSP and what it should be could constitute a valuable opportunity to implement strategies that bridge that gap and obtain successful clinical results in patients, bacterial resistance, and costs.

M. Vallejo,
Abbot Colombia:
Consultant
,
Consulting fee
and
Grant recipient
W. Castaño, None
L. Bustacara, None
I. Loaiza, None
N. Perez, None
See more of: Poster Abstract Session